Renovascular imaging in the NSF era

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 6, 2009, Pages 1323-1334

  Roditi, Giles ^a   Maki, Jeffrey H ^b   Oliveira, George ^b   Michaely, Henrik J ^c  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Functional renal imaging; Magnetic resonance angiography; Nephrogenic systemic fibrosis; Nonenhanced MRA; Renal perfusion; SSFP

Indexed keywords

GADODIAMIDE; GADOLINIUM CHELATE; GADOLINIUM PENTETATE;

ANGIOGRAPHY; ARTERIAL SPIN LABELING; BALANCED STEADY STATE FREE PRECESSION ANGIOGRAPHY; CHRONIC KIDNEY FAILURE; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTRAST INDUCED NEPHROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DOSE RESPONSE; ECHOGRAPHY; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; HYPERTENSION; INCIDENCE; IONIZING RADIATION; KIDNEY FAILURE; KIDNEY INJURY; MAGNETIC RESONANCE ANGIOGRAPHY; NEPHROGENIC SYSTEMIC FIBROSIS; PHASE CONTRAST ANGIOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION EXPOSURE; RENOVASCULAR IMAGING; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; TIME OF FLIGHT MASS SPECTROMETRY; TREATMENT INDICATION;

CONTRAST MEDIA; GADOLINIUM; HUMANS; HYPERTENSION, RENOVASCULAR; MAGNETIC RESONANCE ANGIOGRAPHY; NEPHROGENIC FIBROSING DERMOPATHY; RENAL ARTERY; RENAL ARTERY OBSTRUCTION;

EID: 73649135424     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21977     Document Type: Conference Paper

References (81)

1. Ives NJ, Wheatley K, Stowe RL, et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 2003;18:298-304.
2. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001;344:410-417.
3. Siddiqui S, MacGregor MS, Glynn C, Roditi G, Deighan CJ. Factors predicting outcome in a cohort of patients with atherosclerotic renal artery disease diagnosed by magnetic resonance angiography. Am J Kidney Dis 2005;46:1065-1073.
4. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004;141:674-682.
5. van Jaarsveld BC, Pieterman H, van Dijk LC, et al. Inter-observer variability in the angiographic assessment of renal artery stenosis. DRASTIC study group. Dutch Renal Artery Stenosis Intervention Cooperative. J Hypertens 1999;17(Pt 1):1731-1736.
6. Ota H, Takase K, Rikimaru H, et al. Quantitative vascular measurements in arterial occlusive disease. Radiographics 2005;25:1141-1158.
7. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104-1108.
8. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:2359-2362.
9. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000;356:1000-1001.
10. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001;23:383-393.
11. Kucher C, Steere J, Elenitsas R, Siegel DL, Xu X. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. J Am Acad Dermatol 2006;54(Suppl):S31-S34.
12. Cowper SE, Bucala R, Leboit PE. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis-setting the record straight. Semin Arthritis Rheum 2006;35:208-210.
13. Moreno-Romero JA, Segura S, Mascaro JM Jr, et al. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor. Br J Dermatol 2007;157:783-787.
14. Clorius S, Technau K, Watter T, et al. Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent. Clin Nephrol 2007;68:249-252.
15. Khurana A, Runge VM, Narayanan M, Greene JF Jr, Nickel AE. Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan). Invest Radiol 2007;42:139-145.
16. Collidge TA, Thomson PC, Mark PB, et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 2007;245:168-175.
17. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647-649.
18. Wahba IM, Simpson EL, White K. Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature. Am J Transplant 2007;7:2425-2432.
19. Anavekar NS, Chong AH, Norris R, Dowling J, Goodman D. Nephrogenic systemic fibrosis in a gadolinium-naive renal transplant recipient. Australas J Dermatol 2008;49:44-47.
20. Alhadad A, Mattiasson I, Ivancev K, Gottsater A, Lindblad B. Revascularisation of renal artery stenosis caused by fibromuscular dysplasia: effects on blood pressure during 7-year follow-up are influenced by duration of hypertension and branch artery stenosis [see comment]. J Hum Hypertens 2005;19:761-767.
21. Willoteaux S, Faivre-Pierret M, Moranne O, et al. Fibromuscular dysplasia of the main renal arteries: comparison of contrast-enhanced MR angiography with digital subtraction angiography. Radiology 2006;241:922-929.
22. Garasic J, Rosenfield K. Non-atherosclerotic renovascular disease. In: Heuser R, Henry M, eds. Textbook of peripheral vascular interventions. 2nd edition. London: Informa; 2008. p 544-550.
23. McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006;98:5K-13K.
24. Rabbia C, Valpreda S. Duplex scan sonography of renal artery stenosis. Int Angiol 2003;22:101-115.
25. Desberg AL, Paushter DM, Lammert GK, et al. Renal artery stenosis: evaluation with color Doppler flow imaging. Radiology 1990;177:749-753.
26. Berland LL, Koslin DB, Routh WD, Keller FS. Renal artery stenosis: prospective evaluation of diagnosis with color duplex US compared with angiography. Work in progress. Radiology 1990;174:421-423.
27. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001;135:401-411.
28. Mustert BR, Williams DM, Prince MR. In vitro model of arterial stenosis: correlation of mr signal dephasing and trans-stenotic pressure gradients. Magn Reson Imaging 1998;16:301-310.
29. Schoenberg S, Knopp M, Londy F, et al. Renal artery stenosis: stenosis grading by combined morphologic and functional MR imaging: results of a multicenter multireader analysis. J Am Soc Nephrol 2002;13:158-169.
30. Parker D, Yuan C, Blatter D. MR angiography by multiple thin slab 3D acquisition. Magn Reson Med 1991;17:434-451.
31. Prince M, Schoenberg S, Ward J, Londy F, Wakefield T, Stanley J. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features. Radiology 1997;205:128-136.
32. Schoenberg SO, Knopp MV, Bock M, et al. Renal artery stenosis: grading of hemodynamic changes with cine phase-contrast MR blood flow measurements. Radiology 1997;203:45-53.
33. Lum DP, Johnson KM, Paul RK, et al. Transstenotic pressure gradients: measurement in swine - retrospectively ECG-gated 3D phase-contrast MR angiography versus endovascular pressure-sensing guidewires. Radiology 2007;245:751-760.
34. Edelman RR, Siewert B, Adamis M, Gaa J, Laub G, Wielopolski P. Signal targeting with alternating radiofrequency (STAR) sequences: application to MR angiography. Magn Reson Med 1994;31:233-238.
35. Wielopolski PA, Adamis M, Prasad P, Gaa J, Edelman R. Breathhold 3D STAR MR angiography of the renal arteries using segmented echo planar imaging. Magn Reson Med 1995;33:432-438.
36. Prasad PV, Kim D, Kaiser AM, et al. Noninvasive comprehensive characterization of renal artery stenosis by combination of STAR angiography and EPISTAR perfusion imaging. Magn Reson Med 1997;38:776-787.
37. Scheffler K. Basics of non-invasive angiography contrast-enhanced magnetic resonance angiography. JBR-BTR 2003;86:344-346.
38. Katoh M, Buecker A, Stuber M, Gunther RW, Spuentrup E. Free-breathing renal MR angiography with steady-state free-precession (SSFP) and slab-selective spin inversion: initial results. Kidney Int 2004;66:1272-1278.
39. Spuentrup E, Bornert P, Botnar RM, Groen JP, Manning WJ, Stuber M. Navigator-gated free-breathing three-dimensional balanced fast field echo (TrueFISP) coronary magnetic resonance angiography. Invest Radiol 2002;37:637-642.
40. Spuentrup E, Manning WJ, Bornert P, Kissinger KV, Botnar RM, Stuber M. Renal arteries: navigator-gated balanced fast field-echo projection MR angiography with aortic spin labeling: initial experience. Radiology 2002;225:589-596.
41. Spuentrup E, Buecker A, Meyer J, Gunther RW, Stuber M. Navigator-gated free-breathing 3D balanced FFE projection renal MRA: comparison with contrast-enhanced breath-hold 3D MRA in a swine model. Magn Reson Med 2002;48:739-743.
42. Utsunomiya D, Miyazaki M, Nomitsu Y, et al. Clinical role of non-contrast magnetic resonance angiography for evaluation of renal artery stenosis. Circ J 2008;72:1627-1630.
43. Carr HY. Steady-state free precession in nuclear magnetic resonance. Phys Rev 1958;112:1693.
44. Katoh M, Spuentrup E, Stuber M, Hoogeveen R, Gunther RW, Buecker A. Free-breathing renal magnetic resonance angiography with steady-state free-precession and slab-selective spin inversion combined with radial k-space sampling and water-selective excitation. Magn Reson Med 2005;53:1228-1233.
45. Wyttenbach R, Braghetti A, Wyss M, et al. Renal artery assessment with nonenhanced steady-state free precession versus contrast-enhanced MR angiography. Radiology 2007;245:186-195.
46. Coenegrachts KL, Hoogeveen RM, Vaninbroukx JA, et al. High-spatial-resolution 3D balanced turbo field-echo technique for MR angiography of the renal arteries: initial experience. Radiology 2004;231:237-242.
47. Herborn CU, Watkins DM, Runge VM, Gendron JM, Montgomery ML, Naul LG. Renal arteries: comparison of steady-state free precession MR angiography and contrast-enhanced MR angiography. Radiology 2006;239:263-268.
48. Maki JH, Wilson GJ, Eubank WB, Glickerman DJ, Millan JA, Hoogeveen RM. Navigator-gated MR angiography of the renal arteries: a potential screening tool for renal artery stenosis. AJR Am J Roentgenol 2007;188:W540-W546.
49. Maki JH, Wilson GJ, Eubank WB, Glickerman DJ, Pipavath S, Hoogeveen RM. Steady-state free precession MRA of the renal arteries: breath-hold and navigator-gated techniques vs. CEMRA. J Magn Reson Imaging 2007;26:966-973.
50. Duerk J, Lewin J, Wendt M, Petersilge C. Remember true FISP? A high SNR, near 1-second imaging method for T2-like contrast in interventional MRI at .2 T. J Magn Reson Imaging 1998;8:203-208.
51. Foo T, Ho V, Marcos H, Hood M, Choyke P. MR angiography using steady-state free precession. Magn Reson Med 2002;48:699-706.
52. Nehrke K, Bornert P, Groen J, Smink J, Bock JC. On the performance and accuracy of 2D navigator pulses. Magn Reson Imaging 1999;17:1173-1181.
53. Stuber M, Botnar R, Danias P, Kissinger K, Manning W. Submillimeter three-dimensional coronary MR angiography with realtime navigator correction: comparison of navigator locations. Radiology 1999;212:579-587.
54. Katoh M, Spuentrup E, Stuber M, Hoogeveen RM, Gunther RW, Buecker A. Free-breathing renal magnetic resonance angiography with steady-state free-precession and slab-selective spin inversion combined with radial k-space sampling and water-selective excitation. Magn Reson Med 2005;53:1228-1233.
55. Semelka RC, Corrigan K, Ascher SM, Brown JJ, Colindres RE. Renal corticomedullary differentiation: observation in patients with differing serum creatinine levels. Radiology 1994;190:149-152.
56. Chung JJ, Semelka RC, Martin DR. Acute renal failure: common occurrence of preservation of corticomedullary differentiation on MR images. Magn Reson Imaging 2001;19:789-793.
57. Hricak H, Terrier F, Demas BE. Renal allografts: evaluation by MR imaging. Radiology 1986;159:435-441.
58. Lee VS, Kaur M, Bokacheva L, et al. What causes diminished corticomedullary differentiation in renal insufficiency? J Magn Reson Imaging 2007;25:790-795.
59. Kettritz U, Semelka RC, Brown ED, Sharp TJ, Lawing WL, Colindres RE. MR findings in diffuse renal parenchymal disease. J Magn Reson Imaging 1996;6:136-144.
60. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004;230:652-659.
61. Attenberger UI, Sourbron S, Schoenberg SO, et al. Diagnostic benefit of combined MR angiography and MR renal perfusion measurements. Graz: The International MR-Angio Club; 2008. p 41.
62. Lee VS, Rusinek H, Johnson G, Rofsky NM, Krinsky GA, Weinreb JC. MR renography with low-dose gadopentetate dimeglumine: feasibility. Radiology 2001;221:371-379.
63. Michaely HJ, Kramer H, Oesingmann N, et al. Intraindividual comparison of MR-renal perfusion imaging at 1.5 T and 3.0 T. Invest Radiol 2007;42:406-411.
64. Vallee JP, Lazeyras F, Khan HG, Terrier F. Absolute renal blood flow quantification by dynamic MRI and Gd-DTPA. Eur Radiol 2000;10:1245-1252.
65. Michaely HJ, Schoenberg SO, Oesingmann N, et al. Renal artery stenosis: functional assessment with dynamic MR perfusion measurements-feasibility study. Radiology 2006;238:586-596.
66. Sourbron SP, Michaely HJ, Reiser MF, Schoenberg SO. MRI-measurement of perfusion and glomerular filtration in the human kidney with a separable compartment model. Invest Radiol 2008;43:40-48.
67. Montet X, Ivancevic MK, Belenger J, et al. Noninvasive measurement of absolute renal perfusion by contrast medium-enhanced magnetic resonance imaging. Invest Radiol 2003;38:584-592.
68. Schoenberg SO, Aumann S, Just A, et al. Quantification of renal perfusion abnormalities using an intravascular contrast agent: II. Results in animals and humans with renal artery stenosis. Magn Reson Med 2003;49:288-298.
69. Lee VS, Rusinek H, Noz ME, Lee P, Raghavan M, Kramer EL. Dynamic three-dimensional MR renography for the measurement of single kidney function: initial experience. Radiology 2003;227:289-294.
70. Michoux N, Vallee JP, Pechere-Bertschi A, Montet X, Buehler L, Van Beers BE. Analysis of contrast-enhanced MR images to assess renal function. MAGMA 2006;19:167-179.
71. Lee VS, Rusinek H, Bokacheva L, et al. Renal function measurements from MR renography and a simplified multicompartmental model. Am J Physiol Renal Physiol 2007;292:F1548-F1559.
72. Zhang JL, Rusinek H, Bokacheva L, et al. Functional assessment of the kidney from magnetic resonance and computed tomography renography: impulse retention approach to a multicompartment model. Magn Reson Med 2008;59:278-288.
73. Dujardin M, Luypaert R, Sourbron S, Verbeelen D, Stadnik T, de Mey J. Age dependence of T1 perfusion MRI-based hemodynamic parameters in human kidneys. J Magn Reson Imaging 2009;29:398-403.
74. Rohrschneider WK, Becker K, Hoffend J, et al. Combined static-dynamic MR urography for the simultaneous evaluation of morphology and function in urinary tract obstruction. II. Findings in experimentally induced ureteric stenosis. Pediatr Radiol 2000;30:523-532.
75. Rohrschneider WK, Haufe S, Clorius JH, Troger J. MR to assess renal function in children. Eur Radiol 2003;13:1033-1045.
76. Rohrschneider WK, Haufe S, Wiesel M, et al. Functional and morphologic evaluation of congenital urinary tract dilatation by using combined static-dynamic MR urography: findings in kidneys with a single collecting system. Radiology 2002;224:683-694.
77. Michaely HJ, Schoenberg SO, Ittrich C, Dikow R, Bock M, Guenther M. Renal disease: value of functional magnetic resonance imaging with flow and perfusion measurements. Invest Radiol 2004;39:698-705.
78. Boss A, Martirosian P, Graf H, Claussen CD, Schlemmer HP, Schick F. High resolution MR perfusion imaging of the kidneys at 3 Tesla without administration of contrast media. Rofo 2005;177:1625-1630.
79. Martirosian P, Klose U, Mader I, Schick F. FAIR true-FISP perfusion imaging of the kidneys. Magn Reson Med 2004;51:353-361.
80. Warmuth C, Nagel S, Hegemann O, Wlodarczyk W, Ludemann L. Accuracy of blood flow values determined by arterial spin labeling: a validation study in isolated porcine kidneys. J Magn Reson Imaging 2007;26:353-358.
81. Fenchel M, Martirosian P, Langanke J, et al. Perfusion MR imaging with FAIR true FISP spin labeling in patients with and without renal artery stenosis: initial experience. Radiology 2006;238:1013-1021.